Preblick Ryan
Chief Financial Officer
Preblick Ryan has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jun 10, 2026.
On the most recent filing, Preblick Ryan is listed as Chief Financial Officer at Indivior Pharmaceuticals, Inc. Inside the rolling window, Preblick Ryan reported no open-market purchases and 1 open-market sale totaling $1.4M in INDV.
Companies traded
Other insiders at INDV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Preblick Ryan made?
Preblick Ryan has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Preblick Ryan trade?
Preblick Ryan has filed SEC Form 4 disclosures for 1 company, including INDV.
When was Preblick Ryan's most recent SEC Form 4 filing?
Preblick Ryan's most recent SEC Form 4 filing on Tracefour is dated Jun 10, 2026.
What is Preblick Ryan's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Preblick Ryan is listed as Chief Financial Officer.
What is Preblick Ryan's total buy and sell value in the current window?
Inside the rolling retention window, Preblick Ryan bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Preblick Ryan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 36,000 INDV shares on 2026-06-08, worth $1.4M, per SEC Form 4 filings.